FDA Approves Expanded Solosec Indication

January 26, 2022

Solosec® (secnidazole – Lupin Pharmaceuticals) now has an expanded indication to treat bacterial vaginosis and trichomoniasis in patients who are at least 12 years old.

  • Solosec has been FDA approved for use in adults since 2017. Bacterial vaginosis describes inflammation in the vagina caused by bacterial overgrowth, while trichomoniasis is a sexually transmitted infection caused by a protozoan parasite.
  • Recommended dosing is a single 2g packet of granules taken once by mouth, mixed with applesauce, yogurt, or pudding. If Solosec is being used to treat trichomoniasis, all sexual partners should receive the same dose at the same time.
demo-attachment-261-Group-56
demo-attachment-606-Group-43
demo-attachment-1121-Rectangle-602

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager
demo-attachment-180-Group-4